SCHEMBL4474380

SCHEMBL4474380

CC(C)(C)c1cc2c(c(CN3CCOCC3)c1O)CCC1(CCC1)O2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 9/20 0.38
KDM4E B2RXH2 8/20 0.38
MAPT P10636 4/20 0.38
TDP1 Q9NUW8 1/20 0.38
HSD17B10 Q99714 6/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GAA P10253 6/20 0.35
HPGD P15428 5/20 0.35
GLA P06280 4/20 0.35
CASP1 P29466 4/20 0.35
CASP7 P55210 4/20 0.35
LMNA P02545 2/20 0.35
POLB P06746 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ALOX5 P09917 1/20 0.35
ALOX15 P16050 2/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4462428 0.75 ALDH1A1 (0.35) ALDH1A1KDM4EMAPTTDP1POLB
SCHEMBL5316911 0.74 ALOX15 (0.37) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL6768042 0.68 DRD1 (0.32) ALDH1A1KDM4ETDP1ATMHPGD
SCHEMBL4595668 0.68 ALDH1A1 (0.71) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL6766921 0.68 KDM4E (0.33) ALDH1A1KDM4EMAPTTDP1ATM
Hydrochloric Acid SCHEMBL8843521 0.67 ALDH1A1 (0.69) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL4462820 0.66 ALOX15 (0.41) ALDH1A1KDM4EMAPTTDP1HSD17B10
SCHEMBL6764217 0.65 KDM4E (0.32) ALDH1A1KDM4ETDP1ATMCYP2C9
SCHEMBL6766768 0.65 KDM4E (0.32) ALDH1A1KDM4ETDP1ATMCYP2C9
SCHEMBL6305445 0.65 CNR2 (0.36) MEN1KMT2AALDH1A1POLBCNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576094-B2 Spiro derivatives as lipoxygenase inhibitors ELI LILLY AND COMPANY (US) 2009-08-18 US claimed
US-20060128790-A1 Spiro derivatives as lipoxygenase inhibitors GALILEO PHARMACEUTICALS, INC. 2006-06-15 US claimed
US-7576094-B2 Spiro derivatives as lipoxygenase inhibitors ELI LILLY AND COMPANY (US) 2009-08-18 US disclosed
US-20060128790-A1 Spiro derivatives as lipoxygenase inhibitors GALILEO PHARMACEUTICALS, INC. 2006-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128790-A1 Spiro derivatives as lipoxygenase inhibitors ALOX15B, ALOX5, ALOX15 MEN1 4420/4885KMT2A 3967/4885ALDH1A1 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.